• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Recent Advances in Polymethylene(polyphenyl Isocyanate) (Mn~340-400) and Its Applications in Chemical Biomedicine

Polymethylene(polyphenyl Isocyanate) (Mn~340-400), with the CAS number 9016-87-9, is a critical chemical compound widely used in the biomedical and pharmaceutical industries. Recent studies have highlighted its versatility in drug delivery systems, biomaterial fabrication, and tissue engineering. This research briefing synthesizes the latest findings on its synthesis, functional properties, and emerging applications, providing a comprehensive overview for professionals in the field.

Recent research has focused on optimizing the synthesis of Polymethylene(polyphenyl Isocyanate) to enhance its molecular weight distribution and purity. Advanced polymerization techniques, such as controlled radical polymerization and catalytic methods, have been employed to achieve a more uniform molecular weight (Mn~340-400). These improvements have significantly impacted its performance in biomedical applications, particularly in enhancing the stability and biocompatibility of drug carriers.

One of the most promising applications of Polymethylene(polyphenyl Isocyanate) is in the development of targeted drug delivery systems. Studies have demonstrated its ability to form stable nanoparticles that can encapsulate hydrophobic drugs, improving their solubility and bioavailability. Furthermore, its reactive isocyanate groups allow for surface functionalization with targeting ligands, enabling precise drug delivery to specific tissues or cells. This has opened new avenues for treating cancers and other diseases with high precision and reduced side effects.

In addition to drug delivery, Polymethylene(polyphenyl Isocyanate) has shown potential in tissue engineering. Its mechanical properties and biodegradability make it an excellent candidate for scaffold fabrication. Recent in vitro and in vivo studies have confirmed its ability to support cell adhesion, proliferation, and differentiation, making it a valuable material for regenerative medicine. Researchers are also exploring its use in 3D printing to create customized scaffolds for complex tissue structures.

Despite these advancements, challenges remain in the large-scale production and clinical translation of Polymethylene(polyphenyl Isocyanate)-based products. Issues such as batch-to-batch variability, long-term stability, and potential immunogenicity need to be addressed. Ongoing research is focused on standardizing synthesis protocols and conducting comprehensive toxicity studies to ensure its safety and efficacy in clinical settings.

In conclusion, Polymethylene(polyphenyl Isocyanate) (Mn~340-400) continues to be a material of significant interest in the chemical biomedicine field. Its unique properties and versatility offer numerous opportunities for innovation in drug delivery and tissue engineering. Future research should prioritize overcoming existing challenges to fully realize its potential in improving healthcare outcomes.

• 31027-31-3(4-Isopropylphenyl isocyanate)
• 23138-58-1(1-ethyl-3-isocyanatobenzene)
• 2422-91-5(1,1',1''-Methylidynetris4-isocyanato-benzene (25-35% in ethyl acetate))
• 25686-28-6(Benzene,1,1'-methylenebis[4-isocyanato-, homopolymer)
• 78062-13-2(Benzene, 1-isocyanato-3-[(4-isocyanatophenyl)methyl]-)
• 1034-24-8(Benzene,1,1'-(1,2-ethanediyl)bis[4-isocyanato-)
• 918435-06-0(Benzene, 1-isocyanato-4-(2-phenylethyl)-)
• 23138-50-3(1-ethyl-4-isocyanatobenzene)
• 1823-37-6(4'-Benzylphenyl Isocyanate)
• 2470-48-6(Benzene, 1,1'-(1-methylethylidene)bis[4-isocyanato-)